Magnesium Injection Ensures Steroid Avoidance During Vaccine, Viremia or Immunocompromise
Magnesium Injection Ensures Analgesia and Steroid Avoidance During Vaccination, Viremia or Immunocompromise
1 other identifier
observational
150
1 country
1
Brief Summary
Steroid injections are used for interventional pain management. However, their side-effect of immunosuppression may increase the risk of infections. Magnesium is an alternative anti-nociceptive injection that may be used instead of steroids. Prospective observational study of patients who received magnesium injection for interventional pain therapy, instead of steroid injection. Post-injection data collection includes numerical rating pain score, and sleep quality score. Pain is measured using the numeric pain rating scale. Sleep score is measured using the Likert sleep scale. A change in the pain or sleep scores by 2-points is considered significant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 2, 2020
CompletedFirst Submitted
Initial submission to the registry
May 7, 2023
CompletedFirst Posted
Study publicly available on registry
May 17, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJanuary 27, 2025
January 1, 2025
5.5 years
May 7, 2023
January 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain score, objective measurement using the validated Numeric Pain Rating scale
Pain score, using the Numeric Pain Rating scale of 0 to 10, low scores indicate less pain, high scores indicate worse pain
12 weeks
Secondary Outcomes (1)
Sleep quality score, objective measurement using the validated Likert sleep scale
12 weeks
Study Arms (1)
Adult chronic pain patients
Cohort of adult chronic pain patients, undergoing interventional injection therapy for pain management at a Canadian pain clinic
Interventions
Magnesium injection therapy
Eligibility Criteria
Cohort of consecutive adult patients, undergoing interventional injection therapy for pain management at a Canadian pain clinic
You may qualify if:
- adult chronic pain patients
- previous interventional injection therapy
- consent for interventional injection therapy
- good treatment compliance
- regular sleep diary
- regular pain diary
- informed consent for diary review
- consent for clinical record quality assurance review
You may not qualify if:
- organ insufficiency
- cognitive disorder
- inability to provide consent
- major neuropsychiatric disorder
- unreliable diary
- poor treatment compliance
- previous adverse/allergic reactions to magnesium
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Salem Anaesthesia Pain Clinic
Surrey, British Columbia, V3S 7J1, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Olu Bamgbade, MD,FRCPC
Salem Anaesthesia Pain Clinic
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2023
First Posted
May 17, 2023
Study Start
July 2, 2020
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
January 27, 2025
Record last verified: 2025-01